通过CRISPR进行快速变异致病性分析 激活CRB1在患者衍生纤维细胞中的基因表达
Sang Yoon Moon1,2, Dan Zhang2, Shang-Chih Chen2
1Centre for Ophthalmology and Visual Science, The University of Western Australia, Perth, Australia.
The CRISPR journal
|April 5, 2024
概括
研究人员开发了一种新的CRISPR激活方法,以使用患者细胞快速评估遗传视网膜疾病 (IRD) 基因变异的致病性. 这个平台可以更快地诊断和理解盲目的遗传疾病.
科学领域:
- 遗传学 是一个遗传学.
- 眼科医生 眼科 眼科
- 分子生物学分子生物学
背景情况:
- 遗传性视网膜疾病 (IRD) 是一组多样化的遗传性失明疾病.
- 视网膜基因中的致病变体会导致IRD.
- 目前用于变种病原性评估的方法可能耗时.
研究的目的:
- 开发一种快速的方法来评估IRD基因变异的致病性.
- 利用CRISPR激活 (CRISPRa) 来诱导患者衍生纤维细胞中的视网膜基因表达.
- 为了研究特定的IRD变异的致病机制.
主要方法:
- 使用CRISPR激活 (CRISPRa) 来诱导患者衍生纤维细胞中视网膜基因的表达.
- 分析了视网膜炎染色体患者的纤维细胞.
- 视网膜器官 (RO) 来自患者样本进行比较分析.
- 研究了特定的CRB1变体 (c.4005+1G>A和c.652+5G>C).
主要成果:
- 纤维细胞中CRB1的CRISPRa使得研究病原性变异成为可能.
- 该CRB1c.4005+1GA变异导致CRISPR激活的纤维细胞和RO中的第11个外显子跳转.
- 该CRB1c.652+5GC变异增强了2号外因子跳转,并改变了CRB1异型表达在纤维细胞和RO中.
结论:
- 一个基于CRISPRa的新型平台允许在患者纤维细胞中对IRD基因变异进行转录查.
- 该方法提供了一种可访问的方法,用于对遗传变异的快速致病性评估.
- 这些发现有助于更深入地了解IRD机制和潜在的治疗点.
更多相关视频
08:37A Rapid and Facile Pipeline for Generating Genomic Point Mutants in C. elegans Using CRISPR/Cas9 Ribonucleoproteins
Published on: April 30, 2018
7.6K
10:21Using CRISPR/Cas9 Gene Editing to Investigate the Oncogenic Activity of Mutant Calreticulin in Cytokine Dependent Hematopoietic Cells
Published on: January 5, 2018
13.2K
相关概念视频
01:59CRISPR
50.8K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
50.8K
02:53CRISPR and crRNAs
17.0K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
17.0K